Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supplemental Oxygen in Experimental Hypovolemia
NCT05150418Phase 1Completed
- Sponsor
- Oslo University Hospital
- Start
- Nov 2021
- Primary completion
- Jun 2022
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised trial of oxygen in hypovolemia (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Cardiac output at 35 minutes. Started Nov 2021; status: completed.
02
Drugs
oxygen
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT05150418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05150418.